Exscientia | Results Presentation Deck

Exscientia | Results Presentation Deck | 24 slides

Exscientia · 2023-11

arc beats above · slides in the middle · loops below · scroll → 2 LOOPS

Deck intelligence map

coverage by narrative range · generated from this deck JSON

Narrative range 19 total

Metadata

Components

Metrics

Tools

Frameworks

Beats

Loops

Setup 3 slides 100% 3/3 slides 100% 3/3 slides · 10 hits

— 0/3 slides

66.7% 2/3 slides

— 0/3 slides

100% 3/3 slides

— 0/3 slides

Evidence 12 slides 100% 12/12 slides 100% 12/12 slides · 77 hits

— 0/12 slides

16.7% 2/12 slides 33.3% 4/12 slides 100% 12/12 slides 75% 9/12 slides Key Messages 4 slides 100% 4/4 slides 100% 4/4 slides · 17 hits

— 0/4 slides

100% 4/4 slides

— 0/4 slides

Slide inventory

every slide · same image gating as the playbook

front_matter

Open slide detailBeat · Setup

other

Open slide detailBeat · Setup

summarize

Open slide detailBeat · Setup

present_solution

Open slide detailBeat · EvidenceLoop · Logic Chain

The chart uses a horizontal bar format to represent development stages.present_solution

Open slide detailBeat · EvidenceLoop · Logic Chain

front_matter

Open slide detailBeat · EvidenceLoop · Logic Chain

Uses MIDD (Model-informed drug development) as a strategic framework for clinical progression.plan_implementation

Open slide detailBeat · EvidenceLoop · Logic Chain

The slide uses a human anatomy diagram to map specific patient counts to disease locations.size_opportunity

Open slide detailBeat · EvidenceLoop · Logic Chain

present_solution

Open slide detailBeat · EvidenceLoop · Logic Chain

The slide uses a process flow to show the mechanism of action for a drug candidate.present_solution

Open slide detailBeat · EvidenceLoop · Before After

The slide contrasts irreversible inhibition (depletion) with reversible inhibition (recovery).analyze_data

Open slide detailBeat · EvidenceLoop · Before After

The slide includes two charts: a line chart showing tumour volume over time and a dot plot showing plasma pro-GRP concentration reduction.analyze_data

Open slide detailBeat · EvidenceLoop · Before After

The slide uses box plots for aggregate data and line charts for individual patient sample responses, categorized by differentiation level.analyze_data

Open slide detailBeat · Evidence

The slide uses a heatmap to visualize synergy (green) vs no synergy (light green) across different drug combinations.analyze_data

Open slide detailBeat · Evidence

Includes a heatmap showing synergy scores and two dose-response line charts demonstrating enhanced inhibition in combination treatments.analyze_data

Open slide detailBeat · Evidence

front_matter

Open slide detail

Data shows significant synergistic effects in both models, with OCI-Ly10 showing regression and TMD8 showing synergy despite ibrutinib monotherapy inactivity.analyze_data

Open slide detail

The slide shows dose-response curves for 11 patient samples. The left chart shows significant inhibition of CLL cells (IC50 0.4 µM), while the right chart showsanalyze_data

Open slide detail

The table uses a heatmap-style color coding (red for high risk, green for low risk) to visualize safety metrics.compare_peers

Open slide detail

transition

Open slide detailBeat · Key Messages

Uses a concentric circle diagram to represent the layers of value (Pipeline, Financial, Strategic).present_framework

Open slide detailBeat · Key Messages

Includes footnote regarding fixed term bank deposits and currency basis.analyze_data